EP0547166A4 - - Google Patents

Info

Publication number: EP0547166A4
Authority: EP; European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

EP19910918302

Other versions

EP0547166A1 (en

Inventor

Judy Lieberman

Malcolm Gefter

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Immulogic Pharmaceutical Corp

Tufts Medical Center Inc

Original Assignee

New England Medical Center Hospitals Inc

Immulogic Pharmaceutical Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-09-06

Filing date

1991-09-06

Publication date

1994-03-09

1991-09-06 Application filed by New England Medical Center Hospitals Inc, Immulogic Pharmaceutical Corp filed Critical New England Medical Center Hospitals Inc

1993-06-23 Publication of EP0547166A1 publication Critical patent/EP0547166A1/en

1994-03-09 Publication of EP0547166A4 publication Critical patent/EP0547166A4/xx

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/46—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cell Biology (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Developmental Biology & Embryology (AREA)
Virology (AREA)
Zoology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

EP91918302A 1990-09-06 1991-09-06 Pathogen-specific ctl therapy Ceased EP0547166A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US57882890A	1990-09-06	1990-09-06
US578828		1990-09-06
CA002089488A CA2089488A1 (en)	1990-09-06	1991-09-06	Pathogen-specific ctl therapy

Publications (2)

Publication Number	Publication Date
EP0547166A1 EP0547166A1 (en)	1993-06-23
EP0547166A4 true EP0547166A4 (en)	1994-03-09

Family

ID=25675897

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP91918302A Ceased EP0547166A1 (en)	1990-09-06	1991-09-06	Pathogen-specific ctl therapy

Country Status (4)

Country	Link
EP (1)	EP0547166A1 (en)
AU (1)	AU660422B2 (en)
CA (1)	CA2089488A1 (en)
WO (1)	WO1992004462A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5346989A (en) *	1990-08-22	1994-09-13	Syntello Vaccine Development Kb	Peptides for use in induction of T cell activation against HIV-1
AU662534B2 (en) *	1991-06-03	1995-09-07	Syntello Vaccine Development Ab	Peptides for use in induction of T cell activation against HIV-1
US7300660B2 (en)	1993-11-23	2007-11-27	The Regents Of The University Of California	Abundant extracellular products and methods for their production and use
DK0771322T3 (en)	1993-11-23	2008-11-24	Univ California	Abundant, extracellular products and methods of manufacture and use thereof
US6752993B1 (en)	1993-11-23	2004-06-22	The Regents Of The University Of California	Abundant extracellular product vaccines and methods for their production and use
JPH11511968A (en) *	1995-08-21	1999-10-19	デュークユニバーシティ	Methods for increasing antigen density on antigen presenting cells
US5994308A (en)	1996-02-28	1999-11-30	Board Of Trustees Of Southern Illinois University	Broad spectrum antimicrobial peptides containing a tryptophan triplet and methods of use
US6013660A (en) *	1996-10-02	2000-01-11	The Regents Of The University Of California	Externally targeted prophylactic and chemotherapeutic method and agents
DE19710496A1 (en) *	1997-03-13	1998-09-17	Boehringer Mannheim Gmbh	Method for the detection of antigen-specific T cells after enrichment of mononuclear cell populations

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0260714A2 (en) *	1986-09-19	1988-03-23	Oncogen Limited Partnership	The use of activated t-lymphocytes for preparing a pharmaceutical composition for the treatment of AIDS

1991
- 1991-09-06 AU AU87379/91A patent/AU660422B2/en not_active Ceased
- 1991-09-06 CA CA002089488A patent/CA2089488A1/en not_active Abandoned
- 1991-09-06 WO PCT/US1991/006441 patent/WO1992004462A1/en not_active Application Discontinuation
- 1991-09-06 EP EP91918302A patent/EP0547166A1/en not_active Ceased

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0260714A2 (en) *	1986-09-19	1988-03-23	Oncogen Limited Partnership	The use of activated t-lymphocytes for preparing a pharmaceutical composition for the treatment of AIDS

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO9204462A1 *

Also Published As

Publication number	Publication date
AU8737991A (en)	1992-03-30
CA2089488A1 (en)	1993-03-07
WO1992004462A1 (en)	1992-03-19
EP0547166A1 (en)	1993-06-23
AU660422B2 (en)	1995-06-29

Publication	Publication Date	Title
DE4190992T (en)	1993-02-18
DE4191314T1 (en)	1993-07-15
DE4190941T (en)	1992-04-23
DE4190587T (en)	1993-04-01
FR2657075B1 (en)	1993-03-19
DE4192508T (en)	1993-01-28
FR2664537B1 (en)	1995-05-12
DE4190616T (en)	1993-01-28
DE4192352T (en)	1992-10-08
FR2670510B1 (en)	1994-08-19
FR2670572B1 (en)	1997-02-07
FR2657053B1 (en)	1994-12-16
IN171736B (en)	1992-12-26
AU7524791A (en)	1991-11-14
DE4191689T (en)	1992-08-27
DE4193237T (en)	1992-12-10
FR2658347B1 (en)	1994-08-19
IN171756B (en)	1992-12-26
ECSM90420U (en)	1990-10-15
JPH0491247U (en)	1992-08-10
IN171188B (en)	1992-08-15
IN175790B (en)	1995-08-26
IN173918B (en)	1994-08-06
IN174433B (en)	1994-12-03
IN175646B (en)	1995-07-29

Legal Events

Date	Code	Title	Description
1993-05-07	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1993-06-23	17P	Request for examination filed	Effective date: 19930311
1993-06-23	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE
1994-03-09	A4	Supplementary search report drawn up and despatched	Effective date: 19940114
1994-03-09	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE
1996-04-03	17Q	First examination report despatched	Effective date: 19960219
1997-09-16	GRAG	Despatch of communication of intention to grant	Free format text: ORIGINAL CODE: EPIDOS AGRA
1998-06-05	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED
1998-07-22	18R	Application refused	Effective date: 19980307